← All organizations

Synlogic

For profitWebsite ↗

Also known as: Synlogic

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Jul 5, 2023

Timeline

2010s

Jun 1, 2014
Synlogic— Founded
May 16, 2017
Mirna Therapeutics— Acquired

Drugs by trial phase (9 distinct, 12 trials)

Phase 3 (1 own, 0 via acquisition)

synb1934

Phase 2 (2 own, 2 via acquisition)

Phase 1 (4 own, 0 via acquisition)

Indications

Studied for

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Mirna Therapeutics

Recent trials (11)

NCT05764239Lead sponsorPhase 3Jul 5, 2023
NCT05462132Lead sponsorPhase 1Jul 7, 2022
NCT05377112Lead sponsorEarly Phase 1Mar 29, 2022
NCT04984525Lead sponsorPhase 1Jul 2, 2021
NCT04629170Lead sponsorPhase 1Nov 4, 2020
NCT04534842Lead sponsorPhase 2Aug 25, 2020
NCT04167137Study directorPhase 1Nov 1, 2019
NCT04167137Lead sponsorPhase 1Nov 1, 2019
NCT03516487Lead sponsorPhase 1/Phase 2Apr 2, 2018
NCT03447730Lead sponsorPhase 1/Phase 2Mar 16, 2018
NCT03179878Lead sponsorPhase 1Jun 1, 2017

Details

Founded: Cambridge, MA, US Jun 1, 2014
Last known activity: Jul 5, 2023